Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berg + Schmidt is a global specialist in the development and production of lipid-based ingredients for the life science, cosmetic, and animal nutrition industries. As a member of the Stern-Wywiol Gruppe, the company provides high-quality oleochemical products, including phospholipids, medium-chain triglycerides (MCTs), and fatty alcohols used as excipients and active carriers in pharmaceutical formulations. Their expertise lies in lipid-based drug delivery systems (LBDDS) that enhance the bioavailability and stability of poorly soluble active pharmaceutical ingredients. The company operates modern production facilities and application laboratories to support customized product development and technical service. They are recognized for their BergaPharm line, which focuses on high-purity lipids for pharmaceutical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berg + Schmidt.